As it was reported for colon and glioblastoma cancer, both CD133-positive and CD133-negative cancer cells could initiate tumors [227,228]; thus, the role of CD133 as a marker for tumor-initiating stem cells is still ambiguous. The gene discussed is PROM1; the disease is neoplasm.